{
    "Trade/Device Name(s)": [
        "Assure Pro Blood Glucose Monitoring System",
        "Assure Pro Blood Glucose Meter",
        "Assure Pro Blood Glucose Test Strips",
        "Assure Pro Control Solution"
    ],
    "Submitter Information": "Hypoguard USA, Inc.",
    "510(k) Number": "K053079",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "March 9, 2006",
    "Summary Letter Received Date": "March 10, 2006",
    "Submission Date": "October 28, 2005",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Assure Pro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Assure Pro Blood Glucose Monitoring System intended for quantitative measurement of glucose in fresh capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood for home use by persons with diabetes or in clinical settings by healthcare professionals to monitor effectiveness of diabetes control",
    "fda_folder": "Clinical Chemistry"
}